Literature DB >> 23831337

Immunologically augmented cancer treatment using modern radiotherapy.

Marco Durante1, Norman Reppingen, Kathryn D Held.   

Abstract

Radiation oncology has recently seen tremendous technical advances, resulting in increasing cancer cures. However, malignant neoplasias are systemic diseases and may be lethal even with an excellent tumor local control. Immune therapy has grown to a mature approach in oncology, delivering results impossible only a few years ago. Treatment-limiting mechanisms such as the immune suppressive tumor microenvironment are now to a large extent deciphered, allowing for pharmacological intervention. Interestingly, radiation-based treatment effects have been shown to depend to a large degree on the immune system. Applying the recent advances in radiation therapy in conjunction with immune therapy can be a turning point towards the long-standing aim of curing cancer. Only a detailed understanding of the molecular mechanisms can guide the implementation of combined therapy modalities.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  abscopal effects; combined treatments; immunotherapy; radiotherapy

Mesh:

Year:  2013        PMID: 23831337     DOI: 10.1016/j.molmed.2013.05.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  44 in total

Review 1.  New challenges in high-energy particle radiobiology.

Authors:  M Durante
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

2.  Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis.

Authors:  Kristine L Holm; Randi L Indrevaer; June Helen Myklebust; Arne Kolstad; Jan Øivind Moskaug; Elin H Naderi; Heidi K Blomhoff
Journal:  Immunology       Date:  2016-07-25       Impact factor: 7.397

3.  Harnessing radiation to improve immunotherapy: better with particles?

Authors:  Marco Durante; Silvia Formenti
Journal:  Br J Radiol       Date:  2019-07-22       Impact factor: 3.039

Review 4.  Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastases.

Authors:  Chad G Rusthoven; Tracey E Schefter
Journal:  Hepat Oncol       Date:  2013-12-20

Review 5.  Molecular Signaling in Response to Charged Particle Exposures and its Importance in Particle Therapy.

Authors:  Christine E Hellweg; Arif Ali Chishti; Sebastian Diegeler; Luis F Spitta; Bernd Henschenmacher; Christa Baumstark-Khan
Journal:  Int J Part Ther       Date:  2018-09-21

Review 6.  The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models.

Authors:  Takashi Shimokawa; Liqiu Ma; Ken Ando; Katsutoshi Sato; Takashi Imai
Journal:  Int J Part Ther       Date:  2016-08-29

Review 7.  Emerging Opportunities and Challenges in Cancer Immunotherapy.

Authors:  Theresa L Whiteside; Sandra Demaria; Maria E Rodriguez-Ruiz; Hassane M Zarour; Ignacio Melero
Journal:  Clin Cancer Res       Date:  2016-04-15       Impact factor: 12.531

Review 8.  Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments.

Authors:  Alexander Helm; Daniel K Ebner; Walter Tinganelli; Palma Simoniello; Alessandra Bisio; Valentina Marchesano; Marco Durante; Shigeru Yamada; Takashi Shimokawa
Journal:  Int J Part Ther       Date:  2018-09-21

Review 9.  Tumor-associated macrophages and anti-tumor therapies: complex links.

Authors:  Cristina Belgiovine; Maurizio D'Incalci; Paola Allavena; Roberta Frapolli
Journal:  Cell Mol Life Sci       Date:  2016-03-08       Impact factor: 9.261

10.  Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunity.

Authors:  Dallas B Flies; Xue Han; Tomoe Higuchi; Linghua Zheng; Jingwei Sun; Jessica Jane Ye; Lieping Chen
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.